Search

Search Results

• 

  Pathways for lower extremity superficial vein thrombosis management in an academic medical center

  Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt

  24-03-2025

  https://doi.org/10.4081/btvb.2025.155

  125

  PDF: 25
• 

  Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

  Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

  03-08-2023

  https://doi.org/10.4081/btvb.2023.90

  1333

  PDF: 443
• 

  Antithrombotic therapy in idiopathic infertility

  Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso

  03-10-2024

  https://doi.org/10.4081/btvb.2024.126

  1866

  PDF: 424
• 

  The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

  Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

  04-09-2024

  https://doi.org/10.4081/btvb.2024.144

  806

  PDF: 186

  SUPPLEMENTARY MATERIAL: 87
• 

  Guided antiplatelet therapy in patients undergoing percutaneous coronary intervention

  Marco Cattaneo

  23-06-2023

  https://doi.org/10.4081/btvb.2023.86

  965

  PDF: 186
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  https://doi.org/10.4081/btvb.2024.111

  1409

  PDF: 297
• 

  Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

  Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

  03-11-2022

  https://doi.org/10.4081/btvb.2022.42

  835

  PDF: 278
• 

  2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology

  Bianca Rocca, Emma Hansson, Milan Milojevic, Anders Jeppsson

  16-04-2025

  https://doi.org/10.4081/btvb.2025.178

  56

  PDF: 14
• 

  Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

  Ilaria Nichele, Giuseppe Carli, Alberto Tosetto

  22-04-2024

  https://doi.org/10.4081/btvb.2024.104

  382

  PDF: 123
• 

  Allopurinol-induced acquired von Willebrand syndrome

  Juan Eirís, Marina Suárez-Terrón, Pablo Granados, David Martínez-Campuzano, Ana Rosa Cid, Saturnino Haya, Santiago Bonanad

  25-10-2023

  https://doi.org/10.4081/btvb.2023.88

  1553

  PDF: 174
• 

  Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

  Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

  14-12-2022

  https://doi.org/10.4081/btvb.2022.50

  776

  PDF: 301
• 

  Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

  Ottavia Borghese, Claudio Vincenzoni

  26-06-2024

  https://doi.org/10.4081/btvb.2024.141

  969

  PDF: 243
• 

  Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review

  Rosina Albisinni, Tommaso Marrazzo, Arta Karruli, Sabrina Manduca, Giuseppe Nobile, Nicola Galdieri, Marisa De Feo

  24-10-2022

  https://doi.org/10.4081/btvb.2022.44

  530

  PDF: 175
• 

  Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

  Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

  27-06-2023

  https://doi.org/10.4081/btvb.2023.84

  1207

  PDF: 272

  Supplementary File: 146
• 

  Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

  Ang Li, Emily Zhou

  16-05-2024

  https://doi.org/10.4081/btvb.2024.108

  636

  PDF: 252
• 

  New perspectives for prevention of the post-thrombotic syndrome

  Paolo Prandoni

  22-03-2022

  https://doi.org/10.4081/btvb.2022.20

  1424

  PDF: 434
• 

  The changing landscape of treatment for acquired hemophilia A

  Massimo Franchini, Daniele Focosi

  30-01-2025

  https://doi.org/10.4081/btvb.2025.157

  680

  PDF: 235
• 

  Growing weapons to fight hemophilia

  Pier Mannuccio Mannucci

  23-02-2023

  https://doi.org/10.4081/btvb.2023.64

  724

  PDF: 300
• 

  How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

  Anna Falanga, Hugo Ten Cate, Bianca Rocca

  27-01-2023

  https://doi.org/10.4081/btvb.2023.60

  633

  PDF: 284
• 

  Polycythemia vera and management of the thrombotic risk: an update

  Massimo Franchini

  20-12-2023

  https://doi.org/10.4081/btvb.2023.102

  1814

  PDF: 264
• 

  A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

  Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

  09-03-2023

  https://doi.org/10.4081/btvb.2023.53

  660

  PDF: 343